Concepedia

Emily Y. Jen

EY

8

Publications

420

Citations

8

H-Index

2005

Active since

Affiliations

Center for Drug Evaluation and Research(Current)

United States Food and Drug Administration

The University of Texas MD Anderson Cancer Center

Melanoma Institute Australia

Emily Y. Jen is an author at Center for Drug Evaluation and Research specializing in cell biology, medicine, and immunotherapy.

ORCID

Top concepts

Publications per year

2005–2023

8

Publications

8

FDA Approval: Blinatumomab for Patients with B-cell Precursor Acute Lymphoblastic Leukemia in Morphologic Remission with Minimal Residual Disease

Emily Y. Jen, Qing Xu, Aaron J. Schetter et al. · Clinical Cancer Research · 2018 · 124 citations

Sonic Hedgehog Induces Epidermal Growth Factor Dependent Matrix Infiltration in HaCaT Keratinocytes

Rebecca L. Bigelow, Emily Y. Jen, Maryse Delehedde et al. · Journal of Investigative Dermatology · 2005 · 89 citations · Full text

, , +8

FDA Approval Summary: Tagraxofusp-erzs For Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm

Emily Y. Jen, Xin Gao, Liang Li et al. · Clinical Cancer Research · 2019 · 88 citations

IL‐24 is expressed during wound repair and inhibits TGFα‐induced migration and proliferation of keratinocytes

Nancy Poı̀ndexter, Ryan Williams, Garth Powis et al. · Experimental Dermatology · 2010 · 60 citations

FDA Approval Summary: Oral Azacitidine for Continued Treatment of Adults with Acute Myeloid Leukemia Unable to Complete Intensive Curative Therapy

Emily Y. Jen, Xin Wang, Meng Li et al. · Clinical Cancer Research · 2022 · 22 citations · Full text

Rows per page

1–5 of 8